NIH-funded research P01 program project

How estrogen and heart/metabolic health affect memory in aging women

Official title: Estrogens, Cardiometabolic Health, and Female Cognitive Aging

Funded at Tulane University of Louisiana · NIH-11269206 · Data updated 2026-11-12

This project is seeing if estrogen treatment protects thinking and memory in older women and whether conditions like diabetes or high blood pressure change that effect.

More Aging research and trials

Quick facts

Grant typeP01 program project
Study typeNIH-funded research
Funding institutionTulane University of Louisiana
NIH-funded
Lab location1 site (New Orleans, United States)
Project startMarch 1, 2022
Project endFebruary 28, 2027
Funding year2026
Award (this year)$2,799,973
NIH project number5P01AG071746-05
Project IDNIH-11269206 on NIH RePORTER

Who could benefit from this research

Could help

The findings would be most relevant to postmenopausal women concerned about cognitive aging, including those with or without diabetes, metabolic syndrome, or high blood pressure.

Less likely to help

The hypothesis is that women with existing cardiometabolic disease may not receive cognitive benefit from estrogen therapy.

What this research studies

From a patient's point of view, scientists are using aging female animal models that mimic menopause to give estrogen treatment with and without cardiometabolic disease and then measure brain and memory outcomes. The program includes four linked projects that look at how heart and metabolic health alter estrogen's actions in the brain and how those changes affect memory systems. Researchers will study molecular and cellular mechanisms in the brain as well as systemic cardiometabolic responses to understand why estrogen helps some subjects but not others. The goal is to translate findings into guidance about when estrogen might support cognitive health in aging women.

Why it matters

Potential benefit: If successful, this work could show when menopausal estrogen might help protect memory and who is most likely to benefit or be harmed.

How similar studies have gone: Animal studies have shown estrogen can be neuroprotective, but human trials have produced mixed results and the area remains uncertain.

Where this research is happening

  • Tulane University of Louisiana
    New Orleans, United States
    Active

Researchers

  • Principal investigator: Daniel, Jill M — Tulane University of Louisiana
  • Study coordinator: Daniel, Jill M

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.